These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38217549)
1. Identification of immune-related genes and integrated analysis of immune-cell infiltration in melanoma. He Z; Chen M; Luo Z Aging (Albany NY); 2024 Jan; 16(1):911-927. PubMed ID: 38217549 [TBL] [Abstract][Full Text] [Related]
2. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
3. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987 [TBL] [Abstract][Full Text] [Related]
4. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response. Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156 [TBL] [Abstract][Full Text] [Related]
5. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing. Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991 [TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients. Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z Front Immunol; 2021; 12():659444. PubMed ID: 34040608 [TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis of the tumor microenvironment in melanoma - Constructing a prognostic model based on CD8+ T cell-related genes: An observational study. He Z; Chen M; Luo Z Medicine (Baltimore); 2024 Aug; 103(32):e38924. PubMed ID: 39121331 [TBL] [Abstract][Full Text] [Related]
8. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma. Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482 [TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
10. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648 [TBL] [Abstract][Full Text] [Related]
11. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment. Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510 [TBL] [Abstract][Full Text] [Related]
12. Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma. Liu D; Yang X; Wu X Front Immunol; 2021; 12():663495. PubMed ID: 34025664 [TBL] [Abstract][Full Text] [Related]
13. Identifying a Novel Eight-NK Cell-related Gene Signature for Ovarian Cancer Prognosis Prediction. Li N; Yu K; Huang D; Zhou H; Zeng D Curr Med Chem; 2024; 31(12):1578-1594. PubMed ID: 37650393 [TBL] [Abstract][Full Text] [Related]
14. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma. Qu Y; Zhang S; Zhang Y; Feng X; Wang F Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141 [TBL] [Abstract][Full Text] [Related]
15. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
16. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma. Liang L; Mai S; Mai G; Chen Y; Liu L Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812 [TBL] [Abstract][Full Text] [Related]
17. A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment. Huang R; Mao M; Lu Y; Yu Q; Liao L Aging (Albany NY); 2020 Apr; 12(8):6966-6980. PubMed ID: 32310824 [TBL] [Abstract][Full Text] [Related]
18. Determination of hypoxia signature to predict prognosis and the tumor immune microenvironment in melanoma. Shou Y; Yang L; Yang Y; Zhu X; Li F; Xu J Mol Omics; 2021 Apr; 17(2):307-316. PubMed ID: 33624645 [TBL] [Abstract][Full Text] [Related]
19. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Xie Y; Xu Z; Mei X; Shi W Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905 [TBL] [Abstract][Full Text] [Related]
20. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden. Lin J; Lin Y; Huang Z; Li X Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]